USSTOCK.TODAY
Pre-Market
Log in Sign up
Company overview

What Does Butterfly Network (BFLY) Do? - Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Guide

Updated June 10, 2026 · First published April 14, 2026

Butterfly Network (BFLY) is a US medical device company that makes handheld ultrasound devices built on semiconductor chips. Revenue growth, the path to profitability, and the competitive landscape against large rivals are the key focal points for its stock outlook, earnings, and related-stock dynamics.

Briefs · earnings · signals, first Subscribe

🏢 What kind of company is Butterfly Network?

Butterfly Network is a US medical device company that develops handheld ultrasound devices based on its proprietary technology of integrating ultrasound sensors onto semiconductor chips. Its standout feature is a single-probe structure capable of capturing whole-body imaging.

Its core business consists of handheld point-of-care ultrasound devices and the cloud software that supports them. By offering a low-cost probe that connects to a smartphone, the company is lowering the entry barriers of the traditionally high-priced equipment market.

Here is the sentence rewritten in pure natural English: How does Butterfly Network make money?
Business SegmentRevenue ShareDescription
Device RevenueCoreSales of Butterfly iQ, iQ+, and iQ3 handheld ultrasound probes
Software & SubscriptionsKey Growth DriverSubscription services for cloud-based imaging management and reading workflows
New Applications & LicensingEmerging ExpansionAdjacent-area expansion and partnerships leveraging chip-based technology

The revenue structure is centered on handheld ultrasound device sales, complemented by cloud software subscriptions. A diversification trend is underway in which recurring subscription-based revenue increasingly buffers the volatility of one-off hardware sales, and the chip-based manufacturing structure offers room for cost improvements as scale expands. On a recent annual basis, the company has shown improving profitability metrics alongside revenue growth, placing it in a phase of pursuing both growth and a transition to profitability.

📐 Butterfly Network Market Cap and Company Scale

Market capitalization stands at $1.9B and the company employs 220 people people.

Butterfly Network falls within the small-cap group of the medical device sector by market cap, and the scale gap with large diversified medical device companies such as GEHC and PHG is significant. However, the company has secured a differentiated technology position in the handheld ultrasound niche, giving it a structure with significant growth leverage as the market expands. Currently, capital allocation is tilted toward reinvesting in growth rather than paying dividends.

📈 Butterfly Network Outlook and Stock Performance

1-Year Price Performance
Analyst Consensus
1.0
Sell Hold Strong Buy
Target Price $11 +47.5% Current $7
52-Week Price Range
$7
Low $1 High $10
vs. low +384.35% vs. high -29.15%

In the short term, device shipment volume and the pace of new subscription wins are the variables driving revenue trends. Over the medium to long term, the broader adoption of handheld ultrasound in clinical settings, AI-powered interpretation support, and penetration into emerging markets and primary care are the key growth drivers. On the other hand, entry of large competitors into handheld devices, regulatory approval timelines, and the potential for delayed profitability improvements are factors that warrant monitoring as sources of volatility.

⚔️ Butterfly Network Core Competitive Strengths and Risks

Proprietary chip-based ultrasound technology and low price accessibility serve as strengths, but the scale gap with large competitors and profitability volatility represent risks.

💪 Core Competitive Strengths

Proprietary Chip-Based Technology
A structure that implements ultrasound on a semiconductor delivers technological differentiation in the form of whole-body imaging with a single probe.
Price Accessibility
Pricing significantly lower than conventional high-end ultrasound systems broadens the addressable market.
Subscription Revenue Expansion
Diversification is underway, increasing the share of recurring revenue through cloud software subscriptions.

⚠️ Core Risks

Intensifying Large-Cap Competition
Large medical device companies such as GEHC and PHG are increasing investment in handheld devices, which could intensify competition.
Profitability Volatility
The foundation of profitability is still in the process of becoming firmly established amid the burden of growth investment.
Regulatory & Approval Risk
New applications and market expansion are subject to medical device regulatory approval timelines.

🔄 Butterfly Network Competitors and Related (Beneficiary) Stocks

On the direct competition front, large diversified medical device companies in the same sector, GEHC and PHG, are in direct competition in the handheld ultrasound market. Both companies are entering the point-of-care space with their broad product portfolios and capital resources. On the related-stock front, innovative medical device names such as surgical robotics and imaging specialist ISRG, spinal surgery device maker GMED, and insulin pump maker TNDM are grouped together as part of the same theme basket.

Competitors
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
GEHCGE HealthCare Technologies Inc$64.24-1.4%$29.0B14.82.619.19%0.16%
PHGPHGKoninklijke Philips NV ADR$24.60-1.7%$24.0B18.31.810.24%4.01%
Related stocks (beneficiaries)
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
ISRGIntuitive Surgical Inc$360.46+2.0%$127.3B41.37.017.43%-
GMEDGMEDGlobus Medical Inc$73.56-1.3%$9.9B18.82.111.81%-
TNDMTNDMTandem Diabetes Care Inc$18.31-4.2%$1.3B-9.8-48.03%-

✅ Butterfly Network Investor Checklist

Butterfly Network is a company that continues to pursue efforts to reshape the form and pricing structure of ultrasound equipment. From an investment perspective, it is important to examine both the technological differentiation and the pace of profitability transition together.

CheckpointWhat to VerifyCurrent Status
📈 Revenue MomentumTrend in device sales and subscription revenue growthExpanding trajectory
💵 Profitability TrendProgress in margin improvement and the transition to profitabilityImproving phase
⚔️ Competitive LandscapeLarge medical device companies entering the handheld device marketWarrants monitoring
🔬 Technology & Application ExpansionAI interpretation support and expansion into new application areasUnderway

Entry by large competitors, delays in profitability improvement, and regulatory approval variables are factors that could heighten stock price volatility. Given its small-cap nature, it should also be noted that the stock exhibits high sensitivity to earnings trends.

Butterfly Network is a company pursuing both growth and a transition to profitability in the differentiated niche of chip-based handheld ultrasound. The recommended strategy is to monitor both its technological competitiveness and the pace of profitability improvement, and approach the stock with a staged buying approach and a long-term perspective.

Briefs · earnings · signals, first Subscribe
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →